COVID-19ワクチン (Japanese Wikipedia)

“CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19”. Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 6 March 2020. 2020年3月22日時点のオリジナルよりアーカイブ. 2020年3月23日閲覧.
“Landmark global collaboration launched to defeat COVID-19 pandemic”. CEPI. 24 April 2020. 2020年5月2日時点のオリジナルよりアーカイブ. 2020年5月2日閲覧. The global nature of a pandemic means that any vaccine or medicine that is successfully developed will be needed immediately all over the world. That means that the challenge we face is not only one of R&D but one of manufacturing at scale, and equitable access.
“COVAX: CEPI's response to COVID-19”. Coalition for Epidemic Preparedness Innovations (CEPI). 2020. 2020年12月15日閲覧.
“New vaccines for a safer world”. CEPI. 2020. 2020年12月15日閲覧.
“Our portfolio: partnerships to develop vaccines against COVID-19”. CEPI. 2020. 2020年12月15日閲覧.

chictr.org.cn (Global: low place; Japanese: low place)

clinicaltrials.gov (Global: 5,225^th place; Japanese: low place)

clinicaltrialsregister.eu (Global: low place; Japanese: low place)

cnn.co.jp (Global: 1,952^nd place; Japanese: 119^th place)

cnn.com (Global: 28^th place; Japanese: 188^th place)

contractpharma.com (Global: low place; Japanese: low place)

Kristin Brooks (3 November 2020). “Ramping Up COVID-19 Vaccine Fill and Finish Capacity”. Contract Pharma. 2020年11月25日閲覧.

counterhate.com (Global: low place; Japanese: low place)

“The Disinformation Dozen”. Center for Countering Digital Hate（CCDH） (2021年3月21日). 2022年9月18日閲覧。

cov-lineages.org (Global: low place; Japanese: low place)

“PANGO lineages”. cov-lineages.org. 2021年4月18日閲覧.

ctri.nic.in (Global: low place; Japanese: low place)

doi.org (Global: 2^nd place; Japanese: 6^th place)

elsevier.com (Global: 610^th place; Japanese: 915^th place)

europa.eu (Global: 68^th place; Japanese: 425^th place)

“Safe COVID-19 vaccines for Europeans”. European Commission – European Commission. 2021年2月19日閲覧.
“Questions and Answers: Conditional Marketing Authorisation of COVID-19 Vaccines in the EU”. European Commission (2020年12月11日). 2021年10月4日時点のオリジナルよりアーカイブ。2020年12月29日閲覧。

“EMA starts rolling review of CureVac's COVID-19 vaccine (CVnCoV)”. European Medicines Agency (Press release). 1 December 2020. 2021年2月12日閲覧.
“kostaive”. 欧州医薬品庁（EMA）. 2025年3月15日閲覧。

“COVID-19: MEPs want safe vaccines, full transparency and liability for companies”. European Parliament (2020年9月7日). 2021年10月13日時点のオリジナルよりアーカイブ。2020年12月29日閲覧。

europeanpharmaceuticalreview.com (Global: low place; Japanese: low place)

Durbha M (29 June 2020). “The extra mile: preparing a supply chain for a COVID-19 vaccine”. European Pharmaceutical Review. 2020年9月11日時点のオリジナルよりアーカイブ. 2020年9月13日閲覧.

factcheck.org (Global: 7,075^th place; Japanese: low place)

fda.gov (Global: 447^th place; Japanese: 1,043^rd place)

fiercepharma.com (Global: low place; Japanese: low place)

fnn.jp (Global: 4,795^th place; Japanese: 301^st place)

foldingathome.org (Global: low place; Japanese: low place)

Pande lab. “Client Statistics by OS”. Archive.is. 2020年4月12日時点のオリジナルよりアーカイブ。2020年4月12日閲覧。

forbes.com (Global: 54^th place; Japanese: 269^th place)

fortune.com (Global: 433^rd place; Japanese: 1,942^nd place)

france24.com (Global: 481^st place; Japanese: 2,184^th place)

ft.com (Global: 210^th place; Japanese: 831^st place)

fukuishimbun.co.jp (Global: 7,741^st place; Japanese: 460^th place)

gatesnotes.com (Global: low place; Japanese: low place)

Gates, Bill (30 April 2020). “The vaccine race explained: What you need to know about the COVID-19 vaccine”. The Gates Notes. 2020年5月14日時点のオリジナルよりアーカイブ. 2020年5月2日閲覧.
Gates B (23 April 2020). “The first modern pandemic: The scientific advances we need to stop COVID-19”. The Gates Notes. 2020年5月13日時点のオリジナルよりアーカイブ. 2020年5月6日閲覧.

gavi.org (Global: low place; Japanese: low place)

gendai.media (Global: 1,760^th place; Japanese: 109^th place)

globenewswire.com (Global: 2,614^th place; Japanese: 6,858^th place)

gov.uk (Global: 432^nd place; Japanese: 1,191^st place)

“UK medicines regulator gives approval for first UK COVID-19 vaccine”. Medicines and Healthcare Products Regulatory Agency, Government of the UK. 2 December 2020. 2020年12月2日閲覧.

government.ru (Global: 4,056^th place; Japanese: low place)

harvard.edu (Global: 18^th place; Japanese: 107^th place)

“COVID-19 vaccines” (英語). Harvard Health (2021年1月13日). 2021年6月4日閲覧。
“Coronavirus Resource Center” (英語). Harvard Health (2020年2月28日). 2021年6月4日閲覧。
“COVID-19 vaccines” (英語). Harvard Health (2021年1月13日). 2021年11月20日閲覧。

health.gov.au (Global: low place; Japanese: low place)

“Vaccination numbers and statistics”. Australia Government Department of Health and Aged Care. 2022年8月12日閲覧。

healthychildren.org (Global: low place; Japanese: low place)

“COVID Vaccines for Kids 6 Months & Older: FAQs for Families”. 米国小児科学会 (2022年6月18日). 2022年8月12日閲覧。

hln.be (Global: 1,292^nd place; Japanese: low place)

iata.org (Global: 3,642^nd place; Japanese: low place)

“The time to prepare for COVID-19 vaccine transport is now”. International Air Transport Association. 9 September 2020. 2020年9月12日時点のオリジナルよりアーカイブ. 2020年9月13日閲覧.

ibarakinews.jp (Global: low place; Japanese: 954^th place)

igakuken.or.jp (Global: low place; Japanese: low place)

impress.co.jp (Global: 648^th place; Japanese: 46^th place)

ina-registry.org (Global: low place; Japanese: low place)

independent.co.uk (Global: 36^th place; Japanese: 268^th place)

“Pfizer given protection from legal action over coronavirus vaccine by UK government”. The Independent (2020年12月2日). 2021年5月5日時点のオリジナルよりアーカイブ。2021年5月8日閲覧。

indianexpress.com (Global: 60^th place; Japanese: 2,503^rd place)

“Explained: How India’s first mRNA vaccine for Covid-19 was created”. The Indian Express (2022年6月30日). 2025年3月19日閲覧。

indiatoday.in (Global: 94^th place; Japanese: 4,967^th place)

infektionsschutz.de (Global: low place; Japanese: low place)

“Corona-Schutzimpfung bei Kindern und Jugendlichen”. Bundeszentrale für gesundheitliche Aufklärung (BZgA) (2022年7月8日). 2022年8月12日閲覧。

interpol.int (Global: 5,023^rd place; Japanese: low place)

ismedia.jp (Global: 4,152^nd place; Japanese: 284^th place)

ivi.int (Global: low place; Japanese: low place)

japantimes.co.jp (Global: 389^th place; Japanese: 603^rd place)

jiji.com (Global: 692^nd place; Japanese: 43^rd place)

jnj.com (Global: low place; Japanese: low place)

jpeds.or.jp (Global: low place; Japanese: 3,750^th place)

jsvac.jp (Global: low place; Japanese: low place)

“2024 年度の新型コロナワクチン定期接種に関する⾒解” (PDF). ⼀般社団法⼈⽇本感染症学会、⼀般社団法⼈⽇本呼吸器学会、⽇本ワクチン学会 (2024年10月17日). 2025年3月15日閲覧。

kake.com (Global: low place; Japanese: low place)

kantei.go.jp (Global: 2,533^rd place; Japanese: 224^th place)

“新型コロナワクチンについて”. 首相官邸. 2022年8月12日閲覧。

kumanichi.com (Global: low place; Japanese: 920^th place)

lakartidningen.se (Global: low place; Japanese: low place)

livemint.com (Global: 390^th place; Japanese: 7,256^th place)

m3.com (Global: low place; Japanese: 2,027^th place)

mainichi.jp (Global: 278^th place; Japanese: 16^th place)

manufacturingglobal.com (Global: low place; Japanese: low place)

Cook E (4 September 2020). “UNICEF to lead supply chain for COVID-19 vaccine”. Manufacturing. 2020年11月1日時点のオリジナルよりアーカイブ. 2020年9月13日閲覧.

medical-tribune.co.jp (Global: low place; Japanese: 6,273^rd place)

medicalnewstoday.com (Global: 3,011^th place; Japanese: 8,599^th place)

“What to know about the COVID-19 vaccine and the immune system”. Medical News Today (2022年12月12日). 2023年12月11日閲覧。

medigenvac.com (Global: low place; Japanese: low place)

medrxiv.org (Global: low place; Japanese: low place)

Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ (25 September 2020). Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial. 2020年11月3日時点のオリジナルよりアーカイブ. 2020年12月28日閲覧.

meiji-seika-pharma.co.jp (Global: low place; Japanese: low place)

mhlw.go.jp (Global: 1,656^th place; Japanese: 110^th place)

minsal.cl (Global: low place; Japanese: low place)

“La vacuna CoronaVac demostró ser efectiva en un 89% para evitar hospitalizaciones UCI” [CoronaVac vaccine proved to be 89% effective in preventing ICU hospitalizations] (Press release) (スペイン語). Santiago: Ministry of Health (Chile). 16 April 2021. 2021年4月18日閲覧.
Araos, Rafael (16 April 2021). Efectividad de la vacuna CoronaVac con virus inactivo contra SARS-CoV-2 en Chile [Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile] (PDF) (Report) (スペイン語). Ministry of Health (Chile). p. 12-13. 2021年4月18日閲覧.

mixonline.jp (Global: low place; Japanese: 4,576^th place)

nationalpost.com (Global: 818^th place; Japanese: 3,347^th place)

Desai, Devika (2020年9月10日). “Transporting one single dose of COVID-19 vaccine could take up to 8,000 jumbo planes, says aviation body”. National Post 2020年9月13日閲覧. "The IATA estimated that 8,000 747 cargo planes, at minimum, would be needed to transport a single dose of the vaccine worldwide, but more equipment could be required as administering the vaccine might mean several doses. Vaccines would also have to be stored at a temperature range between two and eight degrees Celsius, which could rule out the use of some types of planes."

nature.com (Global: 234^th place; Japanese: 363^rd place)

nbcnews.com (Global: 137^th place; Japanese: 1,092^nd place)

ndtv.com (Global: 138^th place; Japanese: 2,970^th place)

nejm.org (Global: 2,374^th place; Japanese: 2,486^th place)

Liu, Yang; Liu, Jianying; Xia, Hongjie; Zhang, Xianwen; Fontes-Garfias, Camila R.; Swanson, Kena A.; Cai, Hui; Sarkar, Ritu; Chen, Wei; Cutler, Mark; Cooper, David; Weaver, Scott C.; Muik, Alexander; Sahin, Ugur; Jansen, Kathrin U.; Xie, Xuping; Dormitzer, Philip R.; Shi, Pei-Yong (17 February 2021). “Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report”. New England Journal of Medicine. doi:10.1056/nejmc2102017. PMID 33596352. 2021年2月25日閲覧.

news.cn (Global: 1,956^th place; Japanese: 4,414^th place)

newsweekjapan.jp (Global: 4,574^th place; Japanese: 296^th place)

nhk.or.jp (Global: 145^th place; Japanese: 10^th place)

日本放送協会. “世界のワクチン接種状況｜NHK”. www3.nhk.or.jp. 2021年10月17日閲覧。

nhs.uk (Global: 1,989^th place; Japanese: 4,341^st place)

“SARS (severe acute respiratory syndrome)”. National Health Service. 5 March 2020. 2020年3月9日時点のオリジナルよりアーカイブ. 2020年1月31日閲覧.

nih.gov (Global: 4^th place; Japanese: 24^th place)

“Moderna COVID-19 Vaccine – cx-024414 injection, suspension”. DailyMed. U.S. National Institutes of Health. 2020年12月20日閲覧.{{cite web2}}: CS1メンテナンス: url-status (カテゴリ)
“Pfizer-BioNTech COVID-19 Vaccine – rna ingredient bnt-162b2 injection, suspension”. DailyMed. U.S. National Institutes of Health. 2020年12月14日閲覧.{{cite web2}}: CS1メンテナンス: url-status (カテゴリ)
“Janssen COVID-19 Vaccine - ad26.cov2.s injection, suspension”. DailyMed. U.S. National Institutes of Health. 2021年3月15日閲覧.{{cite web2}}: CS1メンテナンス: url-status (カテゴリ)

nikkei.com (Global: 211^th place; Japanese: 13^th place)

nikkeibp.co.jp (Global: 1,415^th place; Japanese: 95^th place)

nishinippon.co.jp (Global: 1,558^th place; Japanese: 104^th place)

novavax.com (Global: low place; Japanese: low place)

npr.org (Global: 92^nd place; Japanese: 562^nd place)

nytimes.com (Global: 7^th place; Japanese: 63^rd place)

ourworldindata.org (Global: 2,263^rd place; Japanese: 7,457^th place)

pfizer.com (Global: low place; Japanese: low place)

pharm.or.jp (Global: low place; Japanese: 3,917^th place)

pharmaceutical-technology.com (Global: low place; Japanese: low place)

pharmaceuticalprocessingworld.com (Global: low place; Japanese: low place)

pharmiweb.com (Global: low place; Japanese: low place)

Quelch, Rich (14 August 2020). “COVID-19 vaccine delivery – overcoming the supply chain challenges”. PharmiWeb.com. 2020年9月13日閲覧. Delivering a new vaccine for COVID-19 worldwide will be one of the greatest challenges faced by modern pharma. The difficulties are intensified by pre-existing shortcomings in the supply chain.

phe.gov (Global: low place; Japanese: low place)

politifact.com (Global: 3,208^th place; Japanese: low place)

Kertscher T (23 January 2020). “No, there is no vaccine for the Wuhan coronavirus”. PolitiFact. Poynter Institute. 2020年2月7日時点のオリジナルよりアーカイブ. 2020年2月7日閲覧.

precisionvaccinations.com (Global: low place; Japanese: low place)

“VLA2001 COVID-19 Vaccine”. Precision Vaccinations. 31 December 2020. 2021年1月11日閲覧.
“UQ-CSL V451 Vaccine”. precisionvaccinations.com. 2020年12月11日閲覧.

prnasia.com (Global: low place; Japanese: low place)

prnewswire.com (Global: 406^th place; Japanese: 1,806^th place)

publichealthcollaborative.org (Global: low place; Japanese: low place)

qlifepro.com (Global: low place; Japanese: low place)

“GSK、アジュバントの基盤技術を提供”. 株式会社QLife. 14 February 2020. 2020年2月16日閲覧.

raps.org (Global: low place; Japanese: low place)

rdif.ru (Global: low place; Japanese: low place)

reallycorrect.com (Global: low place; Japanese: low place)

reuters.com (Global: 49^th place; Japanese: 67^th place)

rnaj.org (Global: low place; Japanese: low place)

rnz.co.nz (Global: 2,219^th place; Japanese: 8,247^th place)

sankei.com (Global: 323^rd place; Japanese: 15^th place)

sanofi.co.jp (Global: low place; Japanese: low place)

sciencebasedmedicine.org (Global: 5,063^rd place; Japanese: low place)

sciencemag.org (Global: 857^th place; Japanese: 1,005^th place)

Muik, Alexander; Wallisch, Ann-Kathrin; Sänger, Bianca; Swanson, Kena A.; Mühl, Julia; Chen, Wei; Cai, Hui; Maurus, Daniel; Sarkar, Ritu; Türeci, Özlem; Dormitzer, Philip R. (29 January 2021). “Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera”. Science: eabg6105. doi:10.1126/science.abg6105. ISSN 0036-8075. PMID 33514629.{{cite journal2}}: CS1メンテナンス: ページ番号として指定されている記事番号 (カテゴリ)

sciencetimes.com (Global: low place; Japanese: low place)

C, Hannah (10 October 2020). “China Commits to Producing 600 Million Vaccine Doses by the End of 2020”. Science Times. 2020年10月10日時点のオリジナルよりアーカイブ. 2020年10月10日閲覧.

scientificamerican.com (Global: 896^th place; Japanese: 2,100^th place)

selfimmune.com (Global: low place; Japanese: low place)

Shrutirupa (17 April 2021). “IS THIS COVID – 20? | Double Mutant Strain Explained”. Self Immune (アメリカ英語). 2021年4月18日閲覧.

semanticscholar.org (Global: 11^th place; Japanese: 1,537^th place)

shinyapps.io (Global: low place; Japanese: low place)

“COVID-19 vaccine development pipeline (Refresh URL to update)”. Vaccine Centre, London School of Hygiene and Tropical Medicine. 30 November 2020. 2020年12月2日閲覧.
“COVID-19 vaccine development pipeline (Refresh URL to update)”. Vaccine Centre, London School of Hygiene and Tropical Medicine. 1 March 2021. 2021年3月10日閲覧.

ssrn.com (Global: 703^rd place; Japanese: 5,411^th place)

Epperly, David (January 2021). “Evidence For COVID-19 Vaccine Deferred Dose 2 Boost Timing”. SSRN 3760833.
Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, et al. (February 2021). “Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study)”. SSRN 3790399.

Emary, Katherine R. W.; Golubchik, Tanya; Aley, Parvinder K.; Ariani, Cristina V.; Angus, Brian John; Bibi, Sagida; Blane, Beth; Bonsall, David; Cicconi, Paola; Charlton, Sue; Clutterbuck, Elizabeth (2021). “Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)”. SSRN Electronic Journal (英語). doi:10.2139/ssrn.3779160. ISSN 1556-5068.

statnews.com (Global: 8,771^st place; Japanese: low place)

stheadline.com (Global: 1,660^th place; Japanese: low place)

sun-tv.co.jp (Global: low place; Japanese: 2,026^th place)

“サンテレビニュース”. サンテレビニュース (2024年4月17日). 2024年4月18日閲覧。

supplychaindive.com (Global: low place; Japanese: low place)

Kaplan DA (7 July 2020). “3 applications for RFID in the fight against COVID-19”. Supply Chain Dive. 2020年10月2日時点のオリジナルよりアーカイブ. 2020年9月17日閲覧.

swissinfo.ch (Global: 1,485^th place; Japanese: 1,610^th place)

tbs.co.jp (Global: 908^th place; Japanese: 58^th place)

technologyreview.jp (Global: low place; Japanese: 5,949^th place)

ten-navi.com (Global: low place; Japanese: 4,955^th place)

theconversation.com (Global: 928^th place; Japanese: 2,294^th place)

Grenfell, Rob (14 February 2020). “Here's why the WHO says a coronavirus vaccine is 18 months away”. Business Insider. 2020年11月11日閲覧.

theguardian.com (Global: 12^th place; Japanese: 120^th place)

thehindu.com (Global: 52^nd place; Japanese: 2,179^th place)

thelancet.com (Global: 2,393^rd place; Japanese: 4,709^th place)

thestar.com (Global: 336^th place; Japanese: 1,734^th place)

tokyo.lg.jp (Global: 1,357^th place; Japanese: 84^th place)

torontosun.com (Global: 1,440^th place; Japanese: 5,862^nd place)

toyokeizai.net (Global: 1,531^st place; Japanese: 103^rd place)

「日本の｢反ワクチン運動｣がどうも異質に見える訳」東洋経済新報社、2022年1月29日。2022年9月18日閲覧。

trackvaccines.org (Global: low place; Japanese: low place)

“Arcturus Therapeutics Inc: ARCT-154”. VIPER Group COVID19 Vaccine Tracker Team. 2025年3月16日閲覧。

twitter.com (Global: 23^rd place; Japanese: 5^th place)

Folding@home. “https://twitter.com/foldingathome/status/1249778379634675712” (英語). Twitter. 2021年4月10日閲覧。

u-tokyo.ac.jp (Global: 1,856^th place; Japanese: 142^nd place)

“CEPI ニパウイルスワクチンプロジェクト”. 東京大学医科学研究所実験動物研究施設. 25 March 2019. 2020年2月2日閲覧.

“時間との闘い [UTokyo-IIS Bulletin Vol.7 画期的な手法で、より効果的な新型コロナウイルスワクチンの開発に一歩近づく]”. 東京大学生産技術研究所. 2021年8月20日閲覧。

ugent.be (Global: 3,695^th place; Japanese: low place)

Verbeke R, Lentacker I, De Smedt SC, Dewitte H (October 2019). “Three decades of messenger RNA vaccine development”. Nano Today. 28: 100766. doi:10.1016/j.nantod.2019.100766.{{cite journal2}}: CS1メンテナンス: ページ番号として指定されている記事番号 (カテゴリ)

unicef.org (Global: 1,791^st place; Japanese: 5,170^th place)

unodc.org (Global: 2,494^th place; Japanese: 5,404^th place)

“COVID-19-related trafficking of medical products as a threat to public health” (PDF). United Nations Office on Drugs and Crime. 2020. 2020年9月19日時点のオリジナルよりアーカイブ (PDF). 2020年9月16日閲覧.

usatoday.com (Global: 41^st place; Japanese: 199^th place)

vaccine-safety-training.org (Global: low place; Japanese: low place)

“Module 2 – Subunit vaccines”. WHO Vaccine Safety Basics. 2021年3月11日閲覧.

vaccines.gov (Global: low place; Japanese: low place)

“Vaccine Safety – Vaccines”. vaccines.gov. US Department of Health and Human Services. 2020年4月22日時点のオリジナルよりアーカイブ. 2020年4月13日閲覧.

wa.gov (Global: 2,121^st place; Japanese: low place)

“Children ages 5-11 now eligible for Pfizer-BioNTech COVID-19 booster dose”. Washington State Department of Health (2022年5月20日). 2022年8月12日閲覧。

washingtonpost.com (Global: 34^th place; Japanese: 255^th place)

web.archive.org (Global: 1^st place; Japanese: 1^st place)

web.nhk (Global: low place; Japanese: low place)

weforum.org (Global: 1,771^st place; Japanese: 4,096^th place)

“How the massive plan to deliver the COVID-19 vaccine could make history – and leverage blockchain like never before”. World Economic Forum. 17 July 2020. 2020年9月16日時点のオリジナルよりアーカイブ. 2020年9月16日閲覧.
“How can we make enough vaccine for 2 billion people?”. World Economic Forum. 25 August 2020. 2020年9月16日時点のオリジナルよりアーカイブ. 2020年9月16日閲覧.

who.int (Global: 195^th place; Japanese: 376^th place)

“More than 150 countries engaged in COVID-19 vaccine global access facility”. WHO. 15 July 2020. 2020年12月11日閲覧.
“Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine”. World Health Organization. 27 April 2020. 2020年4月30日時点のオリジナルよりアーカイブ. 2020年5月2日閲覧. It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. [The] WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale.
“Draft landscape of COVID 19 candidate vaccines”. World Health Organization. 12 November 2020. 2020年11月16日閲覧.
“SAGE updates COVID-19 vaccination guidance”. WHO (2023年3月28日). 2023年12月9日閲覧。
“World Health Organization timeline – COVID-19”. World Health Organization. 27 April 2020. 2020年4月29日時点のオリジナルよりアーカイブ. 2020年5月2日閲覧.
“The Access to COVID-19 Tools (ACT) Accelerator”. World Health Organization. 2020. 2020年9月25日時点のオリジナルよりアーカイブ. 2020年8月29日閲覧.
“More than 150 countries engaged in COVID-19 vaccine global access facility”. World Health Organization. 15 July 2020. 2020年7月15日時点のオリジナルよりアーカイブ. 2020年7月25日閲覧. COVAX is the only truly global solution to the COVID-19 pandemic. For the vast majority of countries, whether they can afford to pay for their own doses or require assistance, it means receiving a guaranteed share of doses and avoiding being pushed to the back of the queue, as we saw during the H1N1 pandemic a decade ago. Even for those countries that are able to secure their own agreements with vaccine manufacturers, this mechanism represents, through its world-leading portfolio of vaccine candidates, a means of reducing the risks associated with individual candidates failing to show efficacy or gain licensure.
“Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least US$ 153 billion in 2020–21, and US$ 466 billion by 2025, in 10 major economies, according to new report by the Eurasia Group”. World Health Organization. 4 December 2020. 2020年12月11日閲覧.
“Bacille Calmette-Guérin (BCG) vaccination and COVID-19”. World Health Organization (WHO). 12 April 2020. 2020年4月30日時点のオリジナルよりアーカイブ. 2020年5月1日閲覧.
“An international randomised trial of candidate vaccines against COVID-19: Outline of Solidarity vaccine trial” (PDF). World Health Organization (WHO). 9 April 2020. 2020年5月12日時点のオリジナルよりアーカイブ (PDF). 2020年5月9日閲覧.
“Vaccine management and logistics support”. World Health Organization. 2020. 2020年9月13日時点のオリジナルよりアーカイブ. 2020年9月14日閲覧.
“Effective Vaccine Management (EVM) Initiative:Vaccine Management Handbook”. World Health Organization. 9 September 2020. 2018年10月5日時点のオリジナルよりアーカイブ. 2020年9月16日閲覧.
“Interim statement on COVID-19 vaccination for children”. WHO (2022年8月11日). 2022年8月12日閲覧。

wikipedia.org (Global: low place; Japanese: low place)

Mild/Moderate COVID-19 symptoms observed in the Moderna vaccine trials, were only counted as such for vaccinated individuals if they began more than 14 days after their second dose, and required presence of a positive RT-PCR test result along with at least two systemic symptoms (fever above 38ºC, chills, myalgia, headache, sore throat, new olfactory and taste disorder) or just one respiratory symptom (cough, shortness of breath or difficulty breathing, or clinical or radiographical evidence of pneumonia).^[283]
Mild/Moderate COVID-19 symptoms observed in the Pfizer-BioNTech vaccine trials, were only counted as such for vaccinated individuals if they began more than 7 days after their second dose, and required presence of a positive RT-PCR test result along with at least one of the following symptoms: fever; new or increased cough; new or increased shortness of breath; chills; new or increased muscle pain; new loss of taste or smell; sore throat; diarrhea; or vomiting.^[284]
“COVID-19 ACIP Vaccine Recommendations”. Centers for Disease Control and Prevention (CDC). 2021年2月18日閲覧.
Johnson, Carolyn; McGinley, Laura. “Johnson & Johnson seeks emergency FDA authorization for single-shot coronavirus vaccine”. The Washington Post
“Bacille Calmette-Guérin (BCG) vaccination and COVID-19”. World Health Organization (WHO). 12 April 2020. 2020年4月30日時点のオリジナルよりアーカイブ. 2020年5月1日閲覧.
“La vacuna CoronaVac demostró ser efectiva en un 89% para evitar hospitalizaciones UCI” [CoronaVac vaccine proved to be 89% effective in preventing ICU hospitalizations] (Press release) (スペイン語). Santiago: Ministry of Health (Chile). 16 April 2021. 2021年4月18日閲覧.
Araos, Rafael (16 April 2021). Efectividad de la vacuna CoronaVac con virus inactivo contra SARS-CoV-2 en Chile [Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile] (PDF) (Report) (スペイン語). Ministry of Health (Chile). p. 12-13. 2021年4月18日閲覧.
Estudio "Efectividad de la vacuna CoronaVac con virus inactivado contra SARS-CoV-2 en Chile"tran [Study "Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile"] (Online video) (スペイン語). Ministry of Health (Chile). 16 April 2021. 該当時間: 10:12-13:42, 16:59-17:45. 2021年4月18日閲覧.
“Sputnik V demonstrates 97.6% efficacy according to analysis of data from 3.8 million vaccinated persons in Russia making it the most efficient COVID-19 vaccine in the world” (Press release). Moscow: Russian Direct Investment Fund. 19 April 2021. 2021年4月21日閲覧.
“India's variant-fuelled second wave coincided with spike in infected flights landing in Canada”. Toronto Sun. (2021年4月10日) 2021年4月10日閲覧。
“The destinations open to travelers vaccinated against Covid-19”. KAKE. 1 April 2021. 2021年4月3日閲覧.
“Do COVID-19 vaccines cause "turbo cancer"?”. Science-Based Medicine (2022年12月19日). 2023年12月11日閲覧。

wired.com (Global: 193^rd place; Japanese: 739^th place)

Molteni M (26 June 2020). “Vaccine makers turn to microchip tech to beat glass shortages”. Wired. 2020年9月16日時点のオリジナルよりアーカイブ. 2020年9月17日閲覧.

worldcat.org (Global: 5^th place; Japanese: 19^th place)

xinhuanet.com (Global: 309^th place; Japanese: 669^th place)

“China CDC developing novel coronavirus vaccine”. Xinhua. 26 January 2020. 2020年1月26日時点のオリジナルよりアーカイブ. 2020年1月28日閲覧.

yahoo.co.jp (Global: 280^th place; Japanese: 22^nd place)

yahoo.com (Global: 38^th place; Japanese: 203^rd place)

Wake, Damon (4 May 2020). “EU spearheads $8 billion virus fundraiser”. Yahoo Finance. 2020年6月29日時点のオリジナルよりアーカイブ. 2020年5月4日閲覧.

yomiuri.co.jp (Global: 361^st place; Japanese: 28^th place)

youtube.com (Global: 9^th place; Japanese: 8^th place)

“EMA press briefing 11 January 2022”. European Medicines Agency (2022年1月11日). 2023年12月9日閲覧。
Estudio "Efectividad de la vacuna CoronaVac con virus inactivado contra SARS-CoV-2 en Chile"tran [Study "Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile"] (Online video) (スペイン語). Ministry of Health (Chile). 16 April 2021. 該当時間: 10:12-13:42, 16:59-17:45. 2021年4月18日閲覧.

zakzak.co.jp (Global: 1,090^th place; Japanese: 70^th place)

zawya.com (Global: 6,822^nd place; Japanese: low place)

COVID-19ワクチン (Japanese Wikipedia)

abc.net.au (Global: 139th place; Japanese: 1,039th place)

acs.org (Global: 1,248th place; Japanese: 1,765th place)

cen.acs.org

afp.com (Global: 6,649th place; Japanese: low place)

factcheck.afp.com

afpbb.com (Global: 638th place; Japanese: 37th place)

airtable.com (Global: low place; Japanese: low place)

alkhaleejtoday.co (Global: low place; Japanese: low place)

amed.go.jp (Global: low place; Japanese: 8,851st place)

anges.co.jp (Global: low place; Japanese: low place)

archive.today (Global: 14th place; Japanese: 320th place)

asahi.com (Global: 141st place; Japanese: 9th place)

aspistrategist.org.au (Global: low place; Japanese: low place)

astrazeneca.com (Global: low place; Japanese: low place)

barrons.com (Global: 2,737th place; Japanese: 8,336th place)

bbc.co.uk (Global: 8th place; Japanese: 73rd place)

bbc.com (Global: 20th place; Japanese: 100th place)

bharatbiotech.com (Global: low place; Japanese: low place)

bio.org (Global: low place; Japanese: low place)

biorxiv.org (Global: 5,061st place; Japanese: 4,832nd place)

bioworld.com (Global: low place; Japanese: low place)

bloomberg.co.jp (Global: 4,571st place; Japanese: 282nd place)

bloomberg.com (Global: 99th place; Japanese: 542nd place)

bmj.com (Global: 1,226th place; Japanese: 1,988th place)

bmj.com

blogs.bmj.com

bna.bh (Global: low place; Japanese: low place)

brandeis.edu (Global: 8,006th place; Japanese: low place)

brusselstimes.com (Global: 8,796th place; Japanese: low place)

businessinsider.com (Global: 140th place; Japanese: 599th place)

buzzfeed.com (Global: 681st place; Japanese: 355th place)

bworldonline.com (Global: 5,578th place; Japanese: low place)

canada.ca (Global: 1,712th place; Japanese: 7,476th place)

canada.ca

covid-vaccine.canada.ca

health-infobase.canada.ca

carenet.com (Global: low place; Japanese: low place)

cdc.gov (Global: 218th place; Japanese: 712th place)

cdc.gov

covid.cdc.gov

cepi.net (Global: low place; Japanese: low place)

chictr.org.cn (Global: low place; Japanese: low place)

clinicaltrials.gov (Global: 5,225th place; Japanese: low place)

clinicaltrialsregister.eu (Global: low place; Japanese: low place)

cnn.co.jp (Global: 1,952nd place; Japanese: 119th place)

cnn.com (Global: 28th place; Japanese: 188th place)

edition.cnn.com

contractpharma.com (Global: low place; Japanese: low place)

counterhate.com (Global: low place; Japanese: low place)

cov-lineages.org (Global: low place; Japanese: low place)

ctri.nic.in (Global: low place; Japanese: low place)

doi.org (Global: 2nd place; Japanese: 6th place)

elsevier.com (Global: 610th place; Japanese: 915th place)

linkinghub.elsevier.com

europa.eu (Global: 68th place; Japanese: 425th place)

ec.europa.eu

ema.europa.eu

vaccinetracker.ecdc.europa.eu

europarl.europa.eu

europeanpharmaceuticalreview.com (Global: low place; Japanese: low place)

factcheck.org (Global: 7,075th place; Japanese: low place)

fda.gov (Global: 447th place; Japanese: 1,043rd place)

fiercepharma.com (Global: low place; Japanese: low place)

fnn.jp (Global: 4,795th place; Japanese: 301st place)

foldingathome.org (Global: low place; Japanese: low place)

stats.foldingathome.org

forbes.com (Global: 54th place; Japanese: 269th place)

fortune.com (Global: 433rd place; Japanese: 1,942nd place)

france24.com (Global: 481st place; Japanese: 2,184th place)

ft.com (Global: 210th place; Japanese: 831st place)

fukuishimbun.co.jp (Global: 7,741st place; Japanese: 460th place)

gatesnotes.com (Global: low place; Japanese: low place)

gavi.org (Global: low place; Japanese: low place)

gendai.media (Global: 1,760th place; Japanese: 109th place)

globenewswire.com (Global: 2,614th place; Japanese: 6,858th place)

gov.uk (Global: 432nd place; Japanese: 1,191st place)

government.ru (Global: 4,056th place; Japanese: low place)

harvard.edu (Global: 18th place; Japanese: 107th place)

ui.adsabs.harvard.edu

abc.net.au (Global: 139^th place; Japanese: 1,039^th place)

acs.org (Global: 1,248^th place; Japanese: 1,765^th place)

afp.com (Global: 6,649^th place; Japanese: low place)

afpbb.com (Global: 638^th place; Japanese: 37^th place)

amed.go.jp (Global: low place; Japanese: 8,851^st place)

archive.today (Global: 14^th place; Japanese: 320^th place)

asahi.com (Global: 141^st place; Japanese: 9^th place)

barrons.com (Global: 2,737^th place; Japanese: 8,336^th place)

bbc.co.uk (Global: 8^th place; Japanese: 73^rd place)

bbc.com (Global: 20^th place; Japanese: 100^th place)

biorxiv.org (Global: 5,061^st place; Japanese: 4,832^nd place)

bloomberg.co.jp (Global: 4,571^st place; Japanese: 282^nd place)

bloomberg.com (Global: 99^th place; Japanese: 542^nd place)

bmj.com (Global: 1,226^th place; Japanese: 1,988^th place)

brandeis.edu (Global: 8,006^th place; Japanese: low place)

brusselstimes.com (Global: 8,796^th place; Japanese: low place)

businessinsider.com (Global: 140^th place; Japanese: 599^th place)

buzzfeed.com (Global: 681^st place; Japanese: 355^th place)

bworldonline.com (Global: 5,578^th place; Japanese: low place)

canada.ca (Global: 1,712^th place; Japanese: 7,476^th place)

cdc.gov (Global: 218^th place; Japanese: 712^th place)

clinicaltrials.gov (Global: 5,225^th place; Japanese: low place)

cnn.co.jp (Global: 1,952^nd place; Japanese: 119^th place)

cnn.com (Global: 28^th place; Japanese: 188^th place)

doi.org (Global: 2^nd place; Japanese: 6^th place)

elsevier.com (Global: 610^th place; Japanese: 915^th place)

europa.eu (Global: 68^th place; Japanese: 425^th place)

factcheck.org (Global: 7,075^th place; Japanese: low place)

fda.gov (Global: 447^th place; Japanese: 1,043^rd place)

fnn.jp (Global: 4,795^th place; Japanese: 301^st place)

forbes.com (Global: 54^th place; Japanese: 269^th place)

fortune.com (Global: 433^rd place; Japanese: 1,942^nd place)

france24.com (Global: 481^st place; Japanese: 2,184^th place)

ft.com (Global: 210^th place; Japanese: 831^st place)

fukuishimbun.co.jp (Global: 7,741^st place; Japanese: 460^th place)

gendai.media (Global: 1,760^th place; Japanese: 109^th place)

globenewswire.com (Global: 2,614^th place; Japanese: 6,858^th place)

gov.uk (Global: 432^nd place; Japanese: 1,191^st place)

government.ru (Global: 4,056^th place; Japanese: low place)

harvard.edu (Global: 18^th place; Japanese: 107^th place)

hln.be (Global: 1,292^nd place; Japanese: low place)

iata.org (Global: 3,642^nd place; Japanese: low place)

ibarakinews.jp (Global: low place; Japanese: 954^th place)

impress.co.jp (Global: 648^th place; Japanese: 46^th place)

independent.co.uk (Global: 36^th place; Japanese: 268^th place)

indianexpress.com (Global: 60^th place; Japanese: 2,503^rd place)

indiatoday.in (Global: 94^th place; Japanese: 4,967^th place)

interpol.int (Global: 5,023^rd place; Japanese: low place)

ismedia.jp (Global: 4,152^nd place; Japanese: 284^th place)

japantimes.co.jp (Global: 389^th place; Japanese: 603^rd place)

jiji.com (Global: 692^nd place; Japanese: 43^rd place)

jpeds.or.jp (Global: low place; Japanese: 3,750^th place)

kantei.go.jp (Global: 2,533^rd place; Japanese: 224^th place)

kumanichi.com (Global: low place; Japanese: 920^th place)

livemint.com (Global: 390^th place; Japanese: 7,256^th place)

m3.com (Global: low place; Japanese: 2,027^th place)

mainichi.jp (Global: 278^th place; Japanese: 16^th place)

medical-tribune.co.jp (Global: low place; Japanese: 6,273^rd place)

medicalnewstoday.com (Global: 3,011^th place; Japanese: 8,599^th place)

mhlw.go.jp (Global: 1,656^th place; Japanese: 110^th place)

mixonline.jp (Global: low place; Japanese: 4,576^th place)

nationalpost.com (Global: 818^th place; Japanese: 3,347^th place)

nature.com (Global: 234^th place; Japanese: 363^rd place)

nbcnews.com (Global: 137^th place; Japanese: 1,092^nd place)

ndtv.com (Global: 138^th place; Japanese: 2,970^th place)

nejm.org (Global: 2,374^th place; Japanese: 2,486^th place)

news.cn (Global: 1,956^th place; Japanese: 4,414^th place)

newsweekjapan.jp (Global: 4,574^th place; Japanese: 296^th place)

nhk.or.jp (Global: 145^th place; Japanese: 10^th place)

nhs.uk (Global: 1,989^th place; Japanese: 4,341^st place)

nih.gov (Global: 4^th place; Japanese: 24^th place)

nikkei.com (Global: 211^th place; Japanese: 13^th place)

nikkeibp.co.jp (Global: 1,415^th place; Japanese: 95^th place)

nishinippon.co.jp (Global: 1,558^th place; Japanese: 104^th place)